Identification of inflammatory bowel disease-related proteins using a reverse k-nearest neighbor search

Journal of Bioinformatics and Computational Biology

Volumn 12, Issue 4, 2014, Pages

  Suratanee, Apichat ^a   Plaimas, Kitiporn ^b  

^a KING MONGKUT'S UNIVERSITY OF TECHNOLOGY NORTH BANGKOK   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

disease related protein; Inflammatory bowel disease; protein protein interaction network; reverse k nearest neighbor search

Indexed keywords

INTERLEUKIN RECEPTOR; INTERLEUKIN-20 RECEPTOR; JAK2 PROTEIN, HUMAN; JANUS KINASE 2; PROTEIN;

BIOLOGY; GENETIC ASSOCIATION; GENETICS; HUMAN; INFLAMMATORY BOWEL DISEASE; METABOLISM; PROCEDURES; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION;

COMPUTATIONAL BIOLOGY; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INFLAMMATORY BOWEL DISEASES; JANUS KINASE 2; PROTEIN INTERACTION MAPPING; PROTEINS; RECEPTORS, INTERLEUKIN; SIGNAL TRANSDUCTION;

EID: 84906717523     PISSN: 02197200     EISSN: 17576334     Source Type: Journal    
DOI: 10.1142/S0219720014500176     Document Type: Article

References (75)

1. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG, Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review, Gastroenterology 142:46-54 e42; quiz e30, 2012.
2. Cook LC, Hillhouse AE, Myles MH, Lubahn DB, Bryda EC, Davis JW, Franklin CL, The role of estrogen signaling in a mouse model of inflammatory bowel disease: A helicobacter hepaticus model, PLoS One 9:e94209, 2014.
3. Xavier RJ, Podolsky DK, Unravelling the pathogenesis of inflammatory bowel disease, Nature 448:427-434, 2007.
4. Sohrabpour AA, Malekzadeh R, Keshavarzian A, Current therapeutic approaches in inflammatory bowel disease, Curr Pharm Des 16:3668-3683, 2010.
5. McLeod RS, Surgery for inflammatory bowel diseases, Dig Dis 21:168-179, 2003.
6. Barabasi AL, Gulbahce N, Loscalzo J, Network medicine: A network-based approach to human disease, Nat Rev Genet 12:56-68, 2011.
7. Lee Y, Li H, Li J, Rebman E, Achour I, Regan KE, Gamazon ER, Chen JL, Yang XH, Cox NJ, Lussier YA, Network models of genome-wide association studies uncover the topological centrality of protein interactions in complex diseases, J Am Med Inform Assoc 20:619-629, 2013.
8. Suzuki S, Takai-Igarashi T, Fukuoka Y, Wall DP, Tanaka H, Tonellato PJ, Systems analysis of inflammatory bowel disease based on comprehensive gene information, BMC Med Genet 13:25, 2012.
9. Bauer-Mehren A, Bundschus M, Rautschka M, Mayer MA, Sanz F, Furlong LI, Gene-disease network analysis reveals functional modules in mendelian, complex and environmental diseases, PLoS One 6:e20284, 2011.
10. Hirschhorn JN, Lettre G, Progress in genome-wide association studies of human height, Horm Res 71 Suppl 2:5-13, 2009.
11. Lettre G, Rioux JD, Autoimmune diseases: Insights from genome-wide association studies, Hum Mol Genet 17:R116-121, 2008.
12. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, Manolio TA, Potential etiologic and functional implications of genome-wide association loci for human diseases and traits, Proc Natl Acad Sci USA 106:9362-9367, 2009.
13. Batada NN, Hurst LD, Tyers M, Evolutionary and physiological importance of hub proteins, PLoS Comput Biol2:e88, 2006.
14. Estrada E, Virtual identification of essential proteins within the protein interaction network of yeast, Proteomics 6:35-40, 2006.
15. Vallabhajosyula RR, Chakravarti D, Lutfeali S, Ray A, Raval A, Identifying hubs in protein interaction networks, PLoS One 4:e5344, 2009.
16. Jonsson PF, Bates PA, Global topological features of cancer proteins in the human interactome, Bioinformatics 22:2291-2297, 2006.
17. Lin CY, Chin CH, Wu HH, Chen SH, Ho CW, Ko MT, Hubba: Hub objects analyzer - a framework of interactome hubs identification for network biology, Nucleic Acids Res 36:W438-443, 2008.
18. Plaimas K, Eils R, Konig R, Identifying essential genes in bacterial metabolic networks with machine learning methods, BMC Syst Biol 4:56, 2010.
19. Xu J, Li Y, Discovering disease-genes by topological features in human protein-protein interaction network, Bioinformatics 22:2800-2805, 2006.
20. Ghersi D, Singh M, Disentangling function from topology to infer the network properties of disease genes, BMC Syst Biol 7:5, 2013.
21. Chua HN, Sung WK, Wong L, Exploiting indirect neighbours and topological weight to predict protein function from protein-protein interactions, Bioinformatics 22:1623-1630, 2006.
22. Hishigaki H, Nakai K, Ono T, Tanigami A, Takagi T, Assessment of prediction accuracy of protein function from protein-protein interaction data, Yeast 18:523-531, 2001.
23. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Barabasi AL, The human disease network, Proc Natl Acad Sci USA 104:8685-8690, 2007.
24. Oti M, Brunner HG, The modular nature of genetic diseases, Clin Genet 71:1-11, 2007.
25. Wu X, Jiang R, Zhang MQ, Li S, Network-based global inference of human disease genes, Mol Syst Biol 4:189, 2008.
26. Chen L, Zhang L, Zhao Y, Xu L, Shang Y, Wang Q, Li W, Wang H, Li X, Prioritizing risk pathways: A novel association approach to searching for disease pathways fusing SNPs and pathways, Bioinformatics 25:237-242, 2009.
27. Goehler H, Lalowski M, Stelzl U, Waelter S, Stroedicke M, Worm U, Droege A, Lindenberg KS, Knoblich M, Haenig C, Herbst M, Suopanki J, Scherzinger E, Abraham C, Bauer B, Hasenbank R, Fritzsche A, Ludewig AH, Bussow K, Coleman SH, Gutekunst CA, Landwehrmeyer BG, Lehrach H, Wanker EE, A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease, Mol Cell 15:853-865, 2004.
28. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, Chen RO, Brownstein BH, Cobb JP, Tschoeke SK, Miller-Graziano C, Moldawer LL, Mindrinos MN, Davis RW, Tompkins RG, Lowry SF, A network-based analysis of systemic inflammation in humans, Nature 437:1032-1037, 2005.
29. Ghazalpour A, Doss S, Zhang B, Wang S, Plaisier C, Castellanos R, Brozell A, Schadt EE, Drake TA, Lusis AJ, Horvath S, Integrating genetic and network analysis to characterize genes related to mouse weight, PLoS Genet 2:e130, 2006.
30. Ning K, Ng HK, Srihari S, Leong HW, Nesvizhskii AI, Examination of the relationship between essential genes in PPI network and hub proteins in reverse nearest neighbor topology, BMC Bioinformatics 11:505, 2010.
31. Tao Y, Man Lung Y, Nikos M, Reverse nearest neighbor search in metric spaces, IEEE Trans Knowledge Data Eng 18:1239-1252, 2006.
32. Stanoi I, Agrawal D, Abbadi AE, Reverse nearest neighbor queries for dynamic databases, Proc ACM SIGMOD Workshop, 2000, pp. 44-53.
33. Korn F, Muthukrishnan S, Influence sets based on reverse nearest neighbor queries, SIGMOD Rec 29:201-212, 2000.
34. Becker KG, Barnes KC, Bright TJ, Wang SA, The genetic association database, Nat Genet 36:431-432, 2004.
35. Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork P, Jensen LJ, von Mering C, The STRING database in 2011: Functional interaction networks of proteins, globally integrated and scored, Nucleic Acids Res 39:D561-D568, 2011.
36. Granlund A, Flatberg A, Ostvik AE, Drozdov I, Gustafsson BI, Kidd M, Beisvag V, Torp SH, Waldum HL, Martinsen TC, Damas JK, Espevik T, Sandvik AK, Whole genome gene expression meta-analysis of inflammatory bowel disease colon mucosa demonstrates lack of major differences between Crohn's disease and ulcerative colitis, PLoS One 8:e56818, 2013.
37. Lee AY, Eri R, Lyons AB, Grimm MC, Korner H, CC Chemokine ligand 20 and its cognate receptor CCR6 in mucosal T cell immunology and inflammatory bowel disease: Odd couple or axis of evil?, Front Immunol 4:194, 2013.
38. Murata Y, Yamashita A, Saito T, Sugamura K, Hamuro J, The conversion of redox status of peritoneal macrophages during pathological progression of spontaneous inflammatory bowel disease in Janus family tyrosine kinase 3(-/-) and IL-2 receptor gamma(-/-) mice, Int Immunol 14:627-636, 2002.
39. Umbach AT, Luo D, Bhavsar SK, Hosseinzadeh Z, Lang F, Intestinal Na loss and volume depletion in JAK3-deficient mice, Kidney Blood Press Res 37:514-520, 2013.
40. Tesoriere L, Attanzio A, Allegra M, Gentile C, Livrea MA, Indicaxanthin inhibits NADPH oxidase (NOX)-1 activation and NF-kappaB-dependent release of inflammatory mediators and prevents the increase of epithelial permeability in IL-1beta-exposed Caco-2 cells, Br J Nutr 111:415-423, 2014.
41. Zheng CF, Huang Y, Expression of zinc finger protein A20 in pediatric inflammatory bowel disease, Zhonghua Er Ke Za Zhi 49:261-265, 2011.
42. Christophi GP, Rong R, Holtzapple PG, Massa PT, Landas SK, Immune markers and differential signaling networks in ulcerative colitis and Crohn's disease, Inflamm Bowel Dis 18:2342-2356, 2012.
43. Vuitton L, Koch S, Peyrin-Biroulet L, Janus kinase inhibition with tofacitinib: Changing the face of inflammatory bowel disease treatment, Curr Drug Targets 14:1385-1391, 2013.
44. Hassan SW, Doody KM, Hardy S, Uetani N, Cournoyer D, Tremblay ML, Increased susceptibility to dextran sulfate sodium induced colitis in the T cell protein tyrosine phosphatase heterozygous mouse, PLoS One 5:e8868, 2010.
45. Chen C, Zhang X, Wang Y, Analysis of JAK2 and STAT3 polymorphisms in patients with ankylosing spondylitis in Chinese Han population, Clin Immunol 136:442-446, 2010.
46. Carey R, Jurickova I, Ballard E, Bonkowski E, Han X, Xu H, Denson LA, Activation of an IL-6:STAT3-dependent transcriptome in pediatric-onset inflammatory bowel disease, Inflamm Bowel Dis 14:446-457, 2008.
47. Anderson CA, Massey DC, Barrett JC, Prescott NJ, Tremelling M, Fisher SA, Gwilliam R, Jacob J, Nimmo ER, Drummond H, Lees CW, Onnie CM, Hanson C, Blaszczyk K, Ravindrarajah R, Hunt S, Varma D, Hammond N, Lewis G, Attlesey H, Watkins N, Ouwehand W, Strachan D, McArdle W, Lewis CM, Lobo A, Sanderson J, Jewell DP, Deloukas P, Mansfield JC, Mathew CG, Satsangi J, Parkes M, Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship, Gastro-enterology 136:523-529 e523, 2009.
48. Narumi Y, Isomoto H, Shiota M, Sato K, Kondo S, Machida H, Yanagihara K, Mizuta Y, Kohno S, Tsukamoto K, Polymorphisms of PTPN11 coding SHP-2 as biomarkers for ulcerative colitis susceptibility in the Japanese population, J Clin Immunol 29:303-310, 2009.
49. 0-cyclic monophosphate (cAMP) signaling drive SOCS3 expression in inactive ulcerative colitis, Mol Med 18:1412-1419, 2012.
50. Wisner DM, Harris LR, 3rd, Green CL, Poritz LS, Opposing regulation of the tight junction protein claudin-2 by interferon-gamma and interleukin-4, J Surg Res 144:1-7, 2008.
51. Prager M, Buttner J, Haas V, Baumgart DC, Sturm A, Zeitz M, Buning C, The JAK2 variant rs10758669 in Crohn's disease: Altering the intestinal barrier as one mechanism of action, Int J Colorectal Dis 27:565-573, 2012.
52. Liang WD, Li JS, Li KS, Jin J, Yan J, Yang JF, Bi YT, Association of IL-8 gene polymorphisms with inflammatory bowel disease in Chinese patients, Zhonghua Yi Xue Za Zhi 91:1825-1829, 2011.
53. Babu D, Lee JS, Park SY, Thapa D, Choi MK, Kim AR, Park YJ, Kim JA, Involvement of NF-kappaB in the inhibitory actions of Platycarya strobilacea on the TNF-alpha-induced monocyte adhesion to colon epithelial cells and chemokine expression, Arch Pharm Res 31:727-735, 2008.
54. Ohtani K, Ohtsuka Y, Ikuse T, Baba Y, Yamakawa Y, Aoyagi Y, Fujii T, Kudo T, Nagata S, Shimizu T, Increased mucosal expression of GATA-3 and STAT-4 in pediatric ulcerative colitis, Pediatr Int 52:584-589, 2010.
55. Hoffmann JC, Peters K, Henschke S, Herrmann B, Pfister K, Westermann J, Zeitz M, Role of T lymphocytes in rat 2, 4, 6-trinitrobenzene sulphonic acid (TNBS) induced colitis: Increased mortality after gammadelta T cell depletion and no effect of alphabeta T cell depletion, Gut 48:489-495, 2001.
56. Funderburg NT, Stubblefield Park SR, Sung HC, Hardy G, Clagett B, Ignatz-Hoover J, Harding CV, Fu P, Katz JA, Lederman MM, Levine AD, Circulating CD4 and CD8 \+ T cells are activated in inflammatory bowel disease and are associated with plasma markers of inflammation, Immunology 140:87-97, 2013.
57. Maiti AK, Kim-Howard X, Viswanathan P, Guillen L, Rojas-Villarraga A, Deshmukh H, Direskeneli H, Saruhan-Direskeneli G, Canas C, Tobon GJ, Sawalha AH, Chernavsky AC, Anaya JM, Nath SK, Confirmation of an association between rs6822844 at the Il2-Il21 region and multiple autoimmune diseases: Evidence of a general susceptibility locus, Arthritis Rheum 62:323-329, 2010.
58. Stallhofer J, Denk GU, Glas J, Laubender RP, Goke B, Rust C, Brand S, Pusl T, Analysis of IL2/IL21 gene variants in cholestatic liver diseases reveals an association with primary sclerosing cholangitis, Digestion 84:29-35, 2011.
59. Marquez A, Orozco G, Martinez A, Palomino-Morales R, Fernandez-Arquero M, Men-doza JL, Taxonera C, Diaz-Rubio M, Gomez-Garcia M, Nieto A, Lopez-Nevot MA, de la Concha EG, Martin J, Urcelay E, Novel association of the interleukin 2-interleukin 21 region with inflammatory bowel disease, Am J Gastroenterol 104:1968-1975, 2009.
60. Dubinsky MC, Kugathasan S, Kwon S, Haritunians T, Wrobel I, Wahbeh G, Quiros A, Bahar R, Silber G, Farrior S, Stephens M, Teleten N, Panikkath D, Ippoliti A, Vasi-liauskas E, Fleshner P, Williams C, Landers C, Rotter JI, Targan SR, Taylor KD, McGovern DP, Multidimensional prognostic risk assessment identifies association between IL12B variation and surgery in Crohn's disease, Inflamm Bowel Dis 19:1662-1670, 2013.
61. Moon CM, Shin DJ, Son NH, Shin ES, Hong SP, Kim TI, Kim WH, Cheon JH, Genetic variants in the IL12B gene are associated with inflammatory bowel diseases in the Korean population, J Gastroenterol Hepatol 28:1588-1594, 2013.
62. Bouzid D, Amouri A, Fourati H, Marques I, Abida O, Tahri N, Goncalves CP, Masmoudi H, Polymorphisms in the IL2RA and IL2RB genes in inflammatory bowel disease risk, Genet Test Mol Biomarkers 17:833-839, 2013.
63. Parekh R, Kaur N, Liver Injury Secondary to anti-TNF-alpha therapy in inflammatory bowel disease: A case series and review of the literature, Case Rep Gastrointest Med 2014:956463, 2014.
64. Chebli JM, Gaburri PD, Chebli LA, da Rocha Ribeiro TC, Pinto AL, Ambrogini Junior O, Damiao AO, A guide to prepare patients with inflammatory bowel diseases for anti-TNF-alpha therapy, Med Sci Monit 20:487-498, 2014.
65. Schreiber S, Bachmann O, New biologics for treatment of chronic inflammatory bowel diseases, Internist (Berl) 55:367-376, 2014.
66. Holtta V, Klemetti P, Salo HM, Koivusalo A, Pakarinen M, Westerholm-Ormio M, Kolho KL, Vaarala O, Interleukin-17 immunity in pediatric Crohn disease and ulcerative colitis, J Pediatr Gastroenterol Nutr 57:287-292, 2013.
67. Zhu H, Liu J, Zhang H, Wang Z, Lu S, Xu W, Zhong J, Polymorphisms of STAT4 and the risk of inflammatory bowel disease: A case-control study in Chinese Han population, Biomed Rep 1:320-324, 2013.
68. Autschbach F, Funke B, Katzenmeier M, Gassler N, Expression of chemokine receptors in normal and inflamed human intestine, tonsil, and liver-an immunohistochemical analysis with new monoclonal antibodies from the 8th international workshop and conference on human leucocyte differentiation antigens, Cell Immunol 236:110-114, 2005.
69. Schroepf S, Kappler R, Brand S, Prell C, Lohse P, Glas J, Hoster E, Helmbrecht J, Ballauff A, Berger M, von Schweinitz D, Koletzko S, Lacher M, Strong overexpression of CXCR3 axis components in childhood inflammatory bowel disease, Inflamm Bowel Dis 16:1882-1890, 2010.
70. Wu Y, Wang S, Farooq SM, Castelvetere MP, Hou Y, Gao JL, Navarro JV, Oupicky D, Sun F, Li C, A chemokine receptor CXCR2 macromolecular complex regulates neutrophil functions in inflammatory diseases, J Biol Chem 287:5744-5755, 2012.
71. Kanehisa M, Goto S, Sato Y, Kawashima M, Furumichi M, Tanabe M, Data, information, knowledge and principle: Back to metabolism in KEGG, Nucleic Acids Res 42: D199-205, 2014.
72. Sanchez-Munoz F, Dominguez-Lopez A, Yamamoto-Furusho JK, Role of cytokines in inflammatory bowel disease, World J Gastroenterol 14:4280-4288, 2008.
73. Coskun M, Salem M, Pedersen J, Nielsen OH, Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease, Pharmacol Res 76:1-8, 2013.
74. Sugimoto K, Role of STAT3 in inflammatory bowel disease, World J Gastroenterol 14:5110-5114, 2008.
75. Halme L, Paavola-Sakki P, Turunen U, Lappalainen M, Farkkila M, Kontula K, Family and twin studies in inflammatory bowel disease, World J Gastroenterol 12:3668-3672, 2006.